# Exploratory Study Comparing ClearSight System 2D Map to Post Surgery Histopathological Analysis in Lumpectomy

> **NCT02679378** · — · COMPLETED · sponsor: **Clear Cut Medical Ltd.** · enrollment: 220 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** ClearSight™ System

## Key facts

- **NCT ID:** NCT02679378
- **Lead sponsor:** Clear Cut Medical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-12
- **Final completion:** 2018-11
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02679378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02679378, "Exploratory Study Comparing ClearSight System 2D Map to Post Surgery Histopathological Analysis in Lumpectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02679378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*